9 assets in Chronic Pancreatitis

Therapeutic assets addressing Chronic Pancreatitis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Marcaine Chronic Pancreatitis	Johns Hopkins University	P3	BB (68)
Pancrelipase Chronic Pancreatitis	Changhai Hospital	P4	BB (67)
Tocilizumab Chronic Pancreatitis	Soren Schou Olesen	P2	CCC (53)
Lacosamide Chronic Pancreatitis	Indiana University	P1	CC (43)
Aspergillus Oryzae Proteinase Chronic Pancreatitis	Changhai Hospital	N/A	D (30)
Glimepiride Chronic Pancreatitis	Changhai Hospital	N/A	D (30)
Glucophage Chronic Pancreatitis	Changhai Hospital	N/A	D (30)
Pinaverium Chronic Pancreatitis	Yanqing Li	N/A	D (30)